Starbucks Corp. (NASDAQ:SBUX): According to Deutsche Bank, it is possible that there continue to be questions concerning Starbucks’ acquisition of Teavana (NYSE:TEA), including how Teavana will coexist the Starbucks’ Tazo tea brand, and if Teavana products are expected to be sold in Starbucks stores. The firm believes that the acquisition is a modest negative for the Starbucks story, claiming that management is already very preoccupied, but it keeps its Buy rating on the stock.
Hanesbrands Inc. (NYSE:HBI): After the firm met with management, Citigroup views Hanesbrands shares as continuing to have room to run although it saw a 50 percent gain year-to-date. Citi stated that it would be buyers of the stock ahead of the company’s capital and profit transformation. The firm gives the shares a Buy and a $31 price target.
Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.
Nu Skin Enterprises Inc. (NYSE:NUS) management is believed by Deutsche Bank to have continued their practice of setting a low bar able to be cleared handily with its 2013 guidance. The firm views Nu Skin’s valuation as attractive in regards to the company’s growth, and it has decided to reiterates its Buy rating and a $60 price target on the stock.
Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR): Lazard Capital stated that its meeting with Questcor management suggested that Acthar execution continues to be on track although there were recent changes in reimbursement policies from major payors. The firm keeps its Buy rating and a $74 price target on the stock.
Don’t Miss: Apple Gets a Bigger Share of This Pie.